Proteomic analysis of human serum from diabetic retinopathy

International Journal of Ophthalmology

Volumn 4, Issue 6, 2011, Pages 616-622

  Liu, Yin Ping ^a   Hu, Shui Wang ^b   Wu, Zhen Feng ^c   Mei, Li Xin ^c   Lang, Ping ^c   Lu, Xiao He ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c WANNAN MEDICAL COLLEGE   (China)

Author keywords

2 glycoprotein I; Diabetic retinopathy; Difference gel electrophoresis; Proteomics; Serum; Type 2 diabetes

Indexed keywords

EID: 84897584381     PISSN: 22223959     EISSN: 22274898     Source Type: Journal    
DOI: 10.3980/j.issn.2222-3959.2011.06.08     Document Type: Article

References (22)

1. Kempen JH, O'Colmain BJ, Leske MC, Haffner S.M., Klein R., Moss SE, Taylor HR, Hamman RF The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol. 2004;122(4):552-563.
2. Cheung AK, Fung MK, Lo A C, Lam TT, So K.F., Chung SS, Chung SK Aldose reductase deficiency prevents diabetes-induced blood-retinal barrier breakdown, apoptosis, and glial reactivation in the retina of db/db mice. Diabetes. 2005;54(11):3119-3125.
3. Moore TC, Moore JE, Kaji Y, Frizzell N., Usui T, Poulaki V, Campbell I.L., Stitt AW, Gardiner TA, Archer DB, Adamis AP The role of advanced glycation end products in retinal microvascular leukostasis. Invest Ophthmol Vis Sci. 2003;44(10):4457-4464.
4. Garcia-Ramirez M., Canals F, Hernandez C., Colome N, Ferrer C, Carrasco E., Garcia-Arumi J, Simo R. Proteomic analysis of human vitreous fluid by fluorescence-based difference gel electrophoresis (DIGE): a new strategy for identifying potential candidates in the pathogenesis of proliferative diabetic retinopathy. Diabetologia. 2007;50(6):1294-1303.
5. Merchant ML, Klein JB Proteomics and diabetic retinopathy. Clin Lab Med. 2009;29(1):139-149.
6. Drouin P, Blickle JF, Charbonnel B, Eschwege E., Guillausseau PJ, Plouin PF, Daninos JM, Balarac N, Sauvanet JP Diagnosis and classification of diabetes mellitus: the new criteria. Diabetes & metabolism. 1999;25(1):72-83.
7. Wilkinson CP, Ferris FL Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110(9):1677-1682.
8. Liu S, Bai S, Qin Z., Yang Y, Cui Y, Qin Y. Quantitative proteomic analysis of the cerebrospinal fluid of patients with multiple sclerosis. Journal of cellular and molecular medicine. 2009;13(8A):1586-1603.
9. Rao PV, Lu X, Standley M., Pattee P, Neelima G, Girisesh G., Dakshinamurthy KV, Roberts CT, Jr, Nagalla SR. Proteomic identification of urinary biomarkers of diabetic nephropathy. Diabetes Care. 2007;30(3):629-637.
10. Tirumalai RS, Chan KC, Prieto D.A., Issaq HJ, Conrads TP, Veenstra TD Characterization of the low molecular weight human serum proteome. Mol Cell Proteomics. 2003;2(10):1096-1103.
11. Kim SJ, Kim S, Park J., Lee HK, Park KS, Yu HG, Kim Y. Differential expression of vitreous proteins in proliferative diabetic retinopathy. Current Eye Res. 2006;31(3):231-240.
12. Ahn BY, Song ES, Cho Y.J., Kwon OW, Kim JK, Lee N G. Identification of an anti-aldolase autoantibody as a diagnostic marker for diabetic retinopathy by immunoproteomic analysis. Proteomics. 2006;6(4):1200-1209.
13. Kim T, Kim SJ, Kim K, Kang U.B., Lee C., Park KS, Yu HG, Kim Y. Profiling of vitreous proteomes from proliferative diabetic retinopathy and nondiabetic patients. Proteomics. 2007;7(22):4203-4215.
14. Garbis S, Lubec G, Fountoulakis M. Limitations of current proteomics technologies. J Chromatography. 2005;1077(1):1-18.
15. Timms JF, Cramer R. Difference gel electrophoresis. Proteomics. 2008;8(23-24):4886-4897.
16. George J, Harats D, Gilburd B., Afek A, Levy Y, Schneiderman J., Barshack I, Kopolovic J, Shoenfeld Y. Immunolocalization of beta2-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques: potential implications for lesion progression. Circulation. 1999;99(17):2227-2230.
17. Matsuura E, Lopez LR Autoimmune-mediated atherothrombosis. Lupus. 2008;17(10):878-887.
18. Simó R, Higuera M, Garcia-Ramirez M, Canals F, Garcia-Arumi J, Hernandez C. Elevation of apolipoprotein A-I and apolipoprotein H levels in the vitreous fluid and overexpression in the retina of diabetic patients. Arch Ophthalmol. 2008;126(8):1076-1081.
19. Nishi K, Maruyama T, Halsall H.B., Handa T., Otagiri M. Binding of alpha1-acid glycoprotein to membrane results in a unique structural change and ligand release. Biochemistry. 2004;43(32):10513-10519.
20. Christiansen MS, Hommel E, Magid E., Feldt-Rasmussen B. Orosomucoid in urine is a powerful predictor of cardiovascular mortality in normoalbuminuric patients with type 2 diabetes at five years of follow-up. Diabetologia. 2005;48(2):386-393.
21. Gupta N, Shankernarayan NP, Dharmalingam K. Alpha1-acid glycoprotein as a putative biomarker for monitoring the development of the type II reactional stage of leprosy. J Med Microbiol. 2010;59(Pt 4):400-407.
22. Akbay E, Yetkin I, Ersoy R., Kulaksizoglu S, Toruner F, Arslan M. The relationship between levels of alpha1-acid glycoprotein and metabolic parameters of diabetes mellitus. Diabetes, nutrition & metabolism. 2004;17(6):331-335.